Topoisomerase II inhibitor induced leukemia in a patient with AIDS

AIDS

Volumn 15, Issue 3, 2001, Pages 421-423

  Nabil, S ^a   Thomas, F ^a   Douglas, R ^a   Michael, B ^a  

^a UNIVERSITY OF MINNESOTA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CYCLOPHOSPHAMIDE; DOXORUBICIN; ETOPOSIDE; GYRASE INHIBITOR;

ACQUIRED IMMUNE DEFICIENCY SYNDROME; ACUTE GRANULOCYTIC LEUKEMIA; ADULT; ARTICLE; B CELL LYMPHOMA; CASE REPORT; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; LEUKEMIA; MALE; NONHODGKIN LYMPHOMA; PRIORITY JOURNAL;

ACQUIRED IMMUNODEFICIENCY SYNDROME; ADULT; ANTINEOPLASTIC COMBINED CHEMOTHERAPY PROTOCOLS; CYCLOPHOSPHAMIDE; CYTARABINE; DNA TOPOISOMERASES, TYPE II; DOXORUBICIN; ETOPOSIDE; HOMOSEXUALITY, MALE; HUMANS; IDARUBICIN; LEUKEMIA, MYELOCYTIC, ACUTE; LYMPHOMA, AIDS-RELATED; LYMPHOMA, B-CELL; LYMPHOMA, LARGE-CELL; MALE; METHOTREXATE; NEOPLASM METASTASIS; NEOPLASMS, SECOND PRIMARY;

EID: 0035895635     PISSN: 02699370     EISSN: None     Source Type: Journal    
DOI: 10.1097/00002030-200102160-00020     Document Type: Article

References (14)

1. Acute nonlymphocytic leukemia following etoposide and cisplatin combination chemotherapy for advanced non-small cell carcinoma of the lung
2. Secondary acute myeloid leukemia in children treated for acute lymphoid leukemia
3. Acute myeloid leukemia (AML) in NSABP-B25
4. Secondary acute myeloid leukemia following treatment with VP 16 containing regimens for non-Hodgkin's lymphoma
5. Acute myelogenous leukemia after treatment for malignant germ-cell tumors in children
6. The molecular pathogenesis of treatment-induced (secondary) leukemias: Foundations for treatment and prevention
7. Nonrandom chromosomal abnormalities in acute nonlyphocytic leukemia in patients treated for Hodgkin disease and non-Hodgkin lymphoma
8. The balanced and the unbalanced chromosome aberrations of acute myeloid leukemia may develop in different ways and may contribute differently to malignant transformation
9. Rearrangements of the MLL gene in therapy-related acute myeloid leukemia in patients previously treated with agents targeting DNA-topoisomerase II
10. HRX involvement in de novo and secondary leukemias with diverse chromosome 11q23 abnormalities
11. Etoposide (VP16 213)-induced gene alterations: Potential contribution to cell death
12. Report of the Cancer Therapy Evaluation Program (CTEP) Monitoring Plan for secondary acute myeloid leukemia following treatment with epipodophyllotoxins
13. Acquired immunodeficiency syndrome malignancies: Introduction
14. Occurrence and therapy of secondary acute myeloid leukemia in two HIV-infected patients